Atazanavir

Treatment of HIV Infection

Atazanavir is an antiviral medication used to treat human immunodeficiency virus (HIV) infection. It is part of a class of drugs called protease inhibitors. This medication is always used in combination with other antiretroviral drugs to help manage the virus effectively.

The primary goals of using atazanavir include:

• Reducing the viral load, which is the amount of HIV in the blood.
• Helping the immune system function better by maintaining or increasing CD4 cell counts.

Atazanavir is approved for use in adults and children who meet specific weight requirements. It is often prescribed for patients who are starting HIV treatment for the first time, as well as those who have taken HIV medications before.

Limitations of Use

It is important to note that atazanavir is not a cure for HIV or acquired immunodeficiency syndrome (AIDS). While it helps control the infection, it does not eliminate the virus from the body. Additionally, taking this medication does not prevent the spread of HIV to others through sexual contact or blood exposure.

Mechanism of Action

Atazanavir works by targeting a specific enzyme called protease, which the human immunodeficiency virus (HIV) needs to reproduce. This enzyme is essential for the virus to create new, infectious particles.

When HIV infects a cell, it produces long strands of protein. For the virus to become mature and capable of infecting other cells, these strands must be cut into smaller, functional pieces. The protease enzyme acts as the tool that performs this cutting process.

Atazanavir interferes with this process by:

• Binding to the protease enzyme to block its activity.
• Preventing the virus from maturing into an infectious form.
• Stopping the newly formed virus particles from spreading to healthy cells.

By slowing the replication of the virus, atazanavir helps lower the total amount of HIV in the blood, often referred to as the viral load. This allows the immune system to function more effectively. Atazanavir is used as part of a combination therapy because it does not eliminate the virus entirely and works best when paired with other types of antiretroviral drugs.

Common Side Effects

Some people taking atazanavir may experience mild side effects. These often include:

• Nausea and vomiting
• Headache
• Diarrhea or stomach pain
• Trouble sleeping
• Dizziness
• Muscle pain
• Yellowing of the skin or the whites of the eyes

Serious Side Effects

While less common, some side effects can be serious. Seek medical attention immediately for any of the following:

• Severe skin rash, which may be accompanied by blisters, fever, or mouth sores
• Signs of liver problems, such as dark urine, light-colored stools, or persistent pain in the upper right stomach area
• Symptoms of kidney stones, including sharp pain in the back or side, or blood in the urine
• Gallbladder problems, such as pain in the upper right or middle stomach area, nausea, and fever
• Changes in heart rhythm, which may cause dizziness, lightheadedness, or fainting
• High blood sugar, including increased thirst, frequent urination, or blurred vision
• Changes in body fat distribution, such as increased fat in the upper back, neck, or trunk
• Signs of a new infection, which may occur as the immune system becomes more active

Heart Rhythm Changes

Atazanavir can affect the electrical activity of the heart by prolonging the PR interval. This may increase the risk of certain heart rhythm problems, such as atrioventricular (AV) block. Monitoring with an electrocardiogram (ECG) may be necessary for individuals with pre-existing heart conduction conditions or those taking other medications that affect heart rhythm.

Liver and Gallbladder Concerns

This medication frequently causes elevations in bilirubin, which can lead to yellowing of the skin or eyes (jaundice). While this is often not harmful, it must be monitored to ensure it is not a sign of more serious liver injury. People with a history of Hepatitis B or C are at a higher risk for liver complications. Additionally, cases of gallstones and gallbladder inflammation have been reported.

Severe Skin Reactions

While mild rashes are common during the first few weeks of treatment, severe and potentially life-threatening skin reactions, such as Stevens-Johnson syndrome, have occurred. If a rash develops along with fever, general ill feeling, muscle or joint aches, or blisters, immediate medical evaluation is required.

Kidney Health

Kidney stones (nephrolithiasis) have been observed in patients taking atazanavir. Maintaining adequate hydration may help reduce this risk. Long-term use has also been associated with an increased risk of chronic kidney disease in some patients.

Drug Interactions

Atazanavir interacts with a wide variety of medications, which can lead to serious side effects or make the treatment less effective. Significant interactions include:

• Acid-reducing medications: Proton pump inhibitors, H2 blockers, and antacids can significantly lower atazanavir levels in the blood.
• Statins: Certain cholesterol-lowering drugs may reach toxic levels if taken with atazanavir.
• Hormonal contraceptives: Atazanavir may change the levels of hormones in birth control, potentially making them less effective or increasing side effects.

Other Precautions

• Immune Reconstitution Syndrome: The immune system may become overactive after starting treatment, causing an inflammatory response to previous or hidden infections.
• Diabetes and Blood Sugar: New-onset diabetes, worsening of existing diabetes, and high blood sugar (hyperglycemia) have been reported.
• Fat Redistribution: Changes in body fat distribution, such as an increase in fat around the waist or upper back and loss of fat in the arms and legs, may occur.
• Hemophilia: Patients with hemophilia may experience increased spontaneous bleeding.

Pregnancy

Atazanavir is often prescribed during pregnancy to treat HIV and lower the risk of passing the virus to the baby. Because the body processes medication differently during pregnancy, a healthcare provider may need to adjust the dosage or monitor blood levels more frequently. There is a risk that infants exposed to atazanavir in the womb may develop hyperbilirubinemia, which is a yellowing of the skin or eyes, shortly after birth. Pregnant individuals should discuss the benefits and potential risks with their medical team.

Breastfeeding

Health experts generally recommend that individuals with HIV avoid breastfeeding to prevent transmitting the virus to the infant through breast milk. It is currently unknown if atazanavir passes into human breast milk, although it has been detected in the milk of laboratory animals. People taking this medication should consult their healthcare provider about the safest ways to feed their baby.

Available Forms

Atazanavir is provided in oral formulations for the treatment of HIV infection. The available forms include:

• Capsules: These are intended to be swallowed whole with food.
• Oral Powder: This form is designed to be mixed with specific foods or beverages for administration, often used for pediatric patients or those who have difficulty swallowing capsules.

Atazanavir is also available as a fixed-dose combination tablet that contains other antiretroviral medications.

FDA Approval and Indications

Atazanavir was first approved by the U.S. Food and Drug Administration (FDA) in June 2003. It is classified as a protease inhibitor and is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents. The medication is approved for use in adults and pediatric patients who meet specific age and weight criteria.

Regulatory Status

Atazanavir is a prescription-only medication. It is available as a standalone drug and in fixed-dose combinations with other medications, such as cobicistat. It is not approved as a cure for HIV or AIDS, but rather as a component of a chronic management strategy to reduce viral load.

Safety and Monitoring

While atazanavir does not have a boxed warning, the FDA has established several safety requirements and warnings for its use:

• Drug Interactions: The FDA requires extensive labeling regarding drug-drug interactions, as atazanavir can significantly affect the metabolism of other medications, potentially leading to serious or life-threatening reactions.
• Cardiac Warnings: Regulatory labeling includes warnings about PR interval prolongation, which affects the electrical activity of the heart.
• Severe Skin Reactions: There are documented warnings regarding the risk of severe skin reactions, including Stevens-Johnson syndrome.
• Liver Health: Monitoring is required for patients with underlying liver conditions, such as Hepatitis B or C, due to the risk of hepatotoxicity.

The total price you pay for atazanavir can vary based on several factors:

• Generic Availability: Atazanavir is available as a generic medication. Generic versions are typically more affordable than brand-name versions while providing the same therapeutic benefit.
• Insurance Coverage: Most health insurance plans, including Medicare Part D, provide coverage for atazanavir. The specific amount you pay out-of-pocket will depend on your plan's formulary and deductible status.
• Pharmacy Selection: Prices may differ between local retail pharmacies and mail-order options. Comparing prices at different locations can sometimes lead to savings.
• Assistance Programs: Some patients may be eligible for financial assistance through manufacturer programs or non-profit foundations, particularly if they lack insurance coverage.

For the most accurate information regarding your costs, it is best to consult your insurance provider or speak with a pharmacist.